[go: up one dir, main page]

SG11201510201PA - Method for producing renal progenitor cells and drug comprising the same - Google Patents

Method for producing renal progenitor cells and drug comprising the same

Info

Publication number
SG11201510201PA
SG11201510201PA SG11201510201PA SG11201510201PA SG11201510201PA SG 11201510201P A SG11201510201P A SG 11201510201PA SG 11201510201P A SG11201510201P A SG 11201510201PA SG 11201510201P A SG11201510201P A SG 11201510201PA SG 11201510201P A SG11201510201P A SG 11201510201PA
Authority
SG
Singapore
Prior art keywords
drug
same
progenitor cells
renal progenitor
producing renal
Prior art date
Application number
SG11201510201PA
Other languages
English (en)
Inventor
Kenji Osafune
Takafumi Toyohara
Yukiko Yamagishi
Original Assignee
Univ Kyoto
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kyoto, Astellas Pharma Inc filed Critical Univ Kyoto
Publication of SG11201510201PA publication Critical patent/SG11201510201PA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0684Cells of the urinary tract or kidneys
    • C12N5/0687Renal stem cells; Renal progenitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/54Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1841Transforming growth factor [TGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0684Cells of the urinary tract or kidneys
    • C12N5/0686Kidney cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/15Transforming growth factor beta (TGF-β)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/155Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999Small molecules not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11201510201PA 2013-06-11 2014-06-11 Method for producing renal progenitor cells and drug comprising the same SG11201510201PA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013123072 2013-06-11
JP2014092108 2014-04-25
PCT/JP2014/066081 WO2014200115A1 (fr) 2013-06-11 2014-06-11 Procédé de production de cellules précurseurs rénales et médicament contenant des cellules précurseurs rénales

Publications (1)

Publication Number Publication Date
SG11201510201PA true SG11201510201PA (en) 2016-01-28

Family

ID=52022399

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201510201PA SG11201510201PA (en) 2013-06-11 2014-06-11 Method for producing renal progenitor cells and drug comprising the same

Country Status (15)

Country Link
US (1) US11225642B2 (fr)
EP (1) EP3020803B1 (fr)
JP (1) JP6450311B2 (fr)
KR (1) KR102145967B1 (fr)
CN (1) CN105283542A (fr)
AU (1) AU2014279065B2 (fr)
BR (1) BR112015030918A2 (fr)
CA (1) CA2915085C (fr)
ES (1) ES2794074T3 (fr)
IL (1) IL243023B (fr)
MX (1) MX2015017036A (fr)
RU (1) RU2696315C2 (fr)
SG (1) SG11201510201PA (fr)
TW (1) TWI629360B (fr)
WO (1) WO2014200115A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2794860B1 (fr) * 2011-12-19 2017-05-03 Kyoto University Procédé d'induction d'une différentiation de cellules souches pluripotentes humaines en cellules de mésoderme intermédiaire
EP3011014B1 (fr) * 2013-06-14 2024-11-13 The University of Queensland Cellules progénitrices rénales
CA2914479A1 (fr) * 2013-07-29 2015-02-05 F. Hoffmann-La Roche Ag Procede de differenciation de cellules souches pluripotentes en cellules precurseurs renales multi-competentes
KR101853477B1 (ko) * 2015-06-24 2018-04-30 전북대학교산학협력단 Sirt1 발현 조절을 통한 배아줄기세포로부터 신장전구세포로의 분화 조절 방법
EP3313420B1 (fr) 2015-06-25 2024-03-13 The Children's Medical Center Corporation Procédés et compositions se rapportant à l'expansion, l'enrichissement et la conservation de cellules souches hématopoïétiques
SG11201801970XA (en) 2015-09-11 2018-04-27 Astellas Pharma Inc Method for producing renal progenitor cells
JP2018527007A (ja) * 2015-09-17 2018-09-20 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドThe Brigham and Women’s Hospital, Inc. ヒト多能性幹細胞からネフロンを生成する方法
WO2017161001A1 (fr) 2016-03-15 2017-09-21 Children's Medical Center Corporation Procédés et compositions concernant l'expansion de cellules souches hématopoïétiques
WO2017175866A1 (fr) * 2016-04-08 2017-10-12 国立大学法人京都大学 Procédé d'induction de manière sélective de cellules endodermiques à partir de cellules souches pluripotentes
WO2018064323A1 (fr) 2016-09-28 2018-04-05 Organovo, Inc. Utilisation de tissus rénaux modifiés dans des tests
US11685902B2 (en) 2016-10-11 2023-06-27 Tokushima University Production method for kidney-like tissue
JP7274683B2 (ja) * 2017-04-25 2023-05-17 国立大学法人 熊本大学 多能性幹細胞から樹状分岐した集合管を伴う腎臓構造を作製する方法
JP7161775B2 (ja) * 2017-05-25 2022-10-27 国立大学法人京都大学 中間中胚葉細胞から腎前駆細胞への分化誘導方法、および多能性幹細胞から腎前駆細胞への分化誘導方法
US12024721B2 (en) * 2017-08-18 2024-07-02 Wisconsin Alumni Research Foundation Method of differentiating human pluripotent stem cells to podocytes
DK3704227T3 (da) * 2017-10-31 2025-04-07 Murdoch Childrens Res Inst Sammensætning og fremgangsmåde
WO2019124348A1 (fr) 2017-12-19 2019-06-27 国立大学法人京都大学 Nouvelle méthode d'induction de différenciation ostéogénique
EP3828262A4 (fr) * 2018-07-23 2022-03-30 Kyoto University Nouveau marqueur de cellule progénitrice rénale et méthode de concentration de cellules progénitrices rénales l'utilisant
CN116802276A (zh) 2021-01-08 2023-09-22 国立大学法人京都大学 用于扩增培养肾元祖细胞的培养基、扩增培养肾元祖细胞的方法以及肾脏类器官的制造方法
EP4386083A4 (fr) 2021-08-11 2025-11-12 Univ Kyoto Procédé de production de cellules progénitrices interstitielles rénales, cellules produisant de l'érythropoïétine et procédé de production de cellules produisant de la rénine
CN114457006B (zh) * 2022-02-21 2023-07-28 广州华越肾科再生医学科技有限公司 一种通过不连续分化制备肾脏足细胞的方法
CN114702591B (zh) * 2022-05-17 2022-09-23 诺赛联合(北京)生物医学科技有限公司 成体细胞衍生的类器官制备技术
CN117305222B (zh) * 2023-11-28 2024-02-20 广州华越肾科再生医学科技有限公司 多能干细胞分化为肾祖细胞的方法

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
PE20021011A1 (es) 2001-03-23 2003-02-01 Bayer Corp Derivados quinazolinicos como inhibidores de la rho-quinasa
DE60218138T2 (de) 2001-03-23 2007-09-20 Bayer Pharmaceuticals Corp., West Haven Rho-kinase inhibitoren
ES2305435T3 (es) 2002-01-10 2008-11-01 Bayer Healthcare Ag Inhibidores de la rho-quinasa.
JP4423043B2 (ja) 2002-01-23 2010-03-03 バイエル ファーマセチカル コーポレーション Rho−キナーゼ阻害剤
JP4469179B2 (ja) 2002-01-23 2010-05-26 バイエル ファーマセチカル コーポレーション Rhoキナーゼ阻害剤としてのピリミジン誘導体
ES2273047T3 (es) 2002-10-28 2007-05-01 Bayer Healthcare Ag Fenilaminopirimidinas sustituidas con heteroariloxi como inhibidores de rho-cinasa.
US9453219B2 (en) 2003-05-15 2016-09-27 Mello Biotech Taiwan Co., Ltd. Cosmetic designs and products using intronic RNA
AU2003902776A0 (en) * 2003-06-03 2003-06-19 Monash University Method for expanding cells
US20070031966A1 (en) 2005-07-18 2007-02-08 Regents Of The University Of Michigan Renal progenitor cells from embryonic stem cells
US8278104B2 (en) 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
US8048999B2 (en) 2005-12-13 2011-11-01 Kyoto University Nuclear reprogramming factor
CN101641436A (zh) * 2007-01-30 2010-02-03 佐治亚大学研究基金会 用于产生内胚层和中胚层细胞系及多能游走细胞(mmc)的早期中胚层细胞即稳定的中内胚层细胞群
EP2137296A2 (fr) 2007-03-23 2009-12-30 Wisconsin Alumni Research Foundation Reprogrammation d'une cellule somatique
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
EP2198011B1 (fr) 2007-08-31 2016-06-08 Whitehead Institute for Biomedical Research Stimulation de la voie wnt dans la reprogrammation de cellules somatiques
CA2660123C (fr) 2007-10-31 2017-05-09 Kyoto University Methode de reprogrammation nucleaire
AU2008286249B2 (en) 2007-12-10 2013-10-10 Kyoto University Efficient method for nuclear reprogramming
CA2709566A1 (fr) 2007-12-17 2009-06-25 Gliamed, Inc. Cellules souches et procede de reprogrammation de cellules somatiques de mammiferes adultes
JP5945385B2 (ja) 2008-01-16 2016-07-05 リン、シー−ランLIN, Shi−Lung 誘導性組換えrna因子を用いた腫瘍のない多能性胚性幹様細胞の生成
US20100330677A1 (en) 2008-02-11 2010-12-30 Cambridge Enterprise Limited Improved Reprogramming of Mammalian Cells, and Cells Obtained
EP2090649A1 (fr) 2008-02-13 2009-08-19 Fondazione Telethon Procédé de reprogrammation de cellules différentiées
WO2009102983A2 (fr) 2008-02-15 2009-08-20 President And Fellows Of Harvard College Induction efficace de cellules souches multipotentes à l’aide de composés à petites molécules
SG10202103401QA (en) 2008-03-17 2021-05-28 Scripps Research Inst Combined chemical and genetic approaches for generation of induced pluripotent stem cells
WO2009114949A1 (fr) 2008-03-20 2009-09-24 UNIVERSITé LAVAL Procédés permettant de déprogrammer les cellules somatiques et utilisations de ces procédés
KR20110006672A (ko) 2008-04-07 2011-01-20 뉴포텐셜, 인크. Hdac 조절제의 사용을 통한 다능 유전자의 유도에 의한 세포 재프로그래밍
CN101835890B (zh) 2008-06-27 2013-07-24 国立大学法人京都大学 有效建立诱导的多能干细胞的方法
EP2313494A2 (fr) 2008-07-14 2011-04-27 Oklahoma Medical Research Foundation Production de cellules pluripotentes par inhibition de la fonction bright/arid3a
WO2010147612A1 (fr) 2009-06-18 2010-12-23 Lixte Biotechnology, Inc. Procédés de modulation de la régulation cellulaire par inhibition de p53
WO2010033920A2 (fr) 2008-09-19 2010-03-25 Whitehead Institute For Biomedical Research Compositions et procédés pour améliorer la reprogrammation d'une cellule
US20120021519A1 (en) 2008-09-19 2012-01-26 Presidents And Fellows Of Harvard College Efficient induction of pluripotent stem cells using small molecule compounds
WO2010042800A1 (fr) 2008-10-10 2010-04-15 Nevada Cancer Institute Procédés de reprogrammation de cellules somatiques et procédés d'utilisation de telles cellules
WO2010050626A1 (fr) 2008-10-30 2010-05-06 Kyoto University Procédé pour produire des cellules souches pluripotentes induites
US20100111908A1 (en) 2008-11-03 2010-05-06 Fangming Lin Induction of Renal Cells for Treatment of Kidney Disease
WO2010056831A2 (fr) 2008-11-12 2010-05-20 Nupotential, Inc. Reprogrammation d'une cellule par induction d'un gène pluripotent à l'aide d'un modulateur de hdac
US9045737B2 (en) 2008-12-13 2015-06-02 Dnamicroarray, Inc. Artificial three-dimensional microenvironment niche culture
US8828722B2 (en) * 2009-02-26 2014-09-09 Tel Hashomer Medical Research Infrastructure And Services Ltd. Isolated populations of renal stem cells and methods of isolating and using same
WO2010098419A1 (fr) 2009-02-27 2010-09-02 Kyoto University Nouvelle substance de reprogrammation nucléaire
US20120122212A1 (en) 2009-03-06 2012-05-17 Marica Grskovic Tgf-beta pathway inhibitors for enhancement of cellular reprogramming of human cells
US20120076762A1 (en) 2009-03-25 2012-03-29 The Salk Institute For Biological Studies Induced pluripotent stem cell generation using two factors and p53 inactivation
WO2010111409A2 (fr) 2009-03-25 2010-09-30 The Salk Institute For Biological Studies Cellules souches pluripotentes
WO2010115050A2 (fr) 2009-04-01 2010-10-07 The Regents Of The University Of California Microarn spécifiques de cellules souches embryonnaires, qui favorisent la pluripotence induite
US20110088107A1 (en) 2009-04-24 2011-04-14 Yaqub Hanna Compositions and methods for deriving or culturing pluripotent cells
WO2010147395A2 (fr) 2009-06-16 2010-12-23 Korea Research Institute Of Bioscience And Biotechnology Composition de milieu comprenant un neuropeptide y pour la génération, le maintien, la croissance non différenciée prolongée de cellules souches pluripotentes et procédé de culture de cellules souches pluripotentes l'utilisant
EP2596096B1 (fr) * 2010-07-21 2018-01-31 Kyoto University Procédé pour induire la différenciation d'une cellule souche pluripotente humaines en cellule de mésoderme humain
EP2794860B1 (fr) 2011-12-19 2017-05-03 Kyoto University Procédé d'induction d'une différentiation de cellules souches pluripotentes humaines en cellules de mésoderme intermédiaire

Also Published As

Publication number Publication date
EP3020803B1 (fr) 2020-03-11
RU2015156492A (ru) 2017-07-14
EP3020803A1 (fr) 2016-05-18
BR112015030918A2 (pt) 2017-12-05
WO2014200115A1 (fr) 2014-12-18
AU2014279065B2 (en) 2020-04-09
RU2015156492A3 (fr) 2018-04-02
US20160137985A1 (en) 2016-05-19
CA2915085A1 (fr) 2014-12-18
TWI629360B (zh) 2018-07-11
KR20160019509A (ko) 2016-02-19
EP3020803A4 (fr) 2017-02-22
AU2014279065A1 (en) 2016-01-21
US11225642B2 (en) 2022-01-18
KR102145967B1 (ko) 2020-08-19
ES2794074T3 (es) 2020-11-17
MX2015017036A (es) 2016-07-21
IL243023B (en) 2019-05-30
JPWO2014200115A1 (ja) 2017-02-23
RU2696315C2 (ru) 2019-08-01
TW201536917A (zh) 2015-10-01
JP6450311B2 (ja) 2019-01-09
CA2915085C (fr) 2021-04-27
CN105283542A (zh) 2016-01-27

Similar Documents

Publication Publication Date Title
IL243023B (en) A method for producing kidney stem cells and a drug containing them
SG11201510238TA (en) Renal progenitor cells
GB2527951B (en) Storage system
ZA201500324B (en) Plantsurface structure and modules and method for forming the same
EP3064568A4 (fr) Structure poreuse et son procédé de fabrication
EP2944462A4 (fr) Stratifié, et procédé de fabrication de celui-ci
PL2670591T3 (pl) Element struktury i sposób wytwarzania tego elementu
IL243605B (en) Metallo-organic materials and a method for their preparation
ZA201509017B (en) Pcd elements and process for making the same
GB201406038D0 (en) Autotroph-based deodorizer and method for manufacturing the same
IL240423B (en) Arrangement for a filter and method for its use
PL3040074T3 (pl) Preparat iniekcyjny i sposób jego wytwarzania
EP3026280A4 (fr) Palier fritté et son procédé de production
EP3024081A4 (fr) Procédé de production de cellule
EP3015742A4 (fr) Crémaillère et procédé de fabrication de crémaillère
PT3038609T (pt) Modificadores de resposta de células t citotóxicas
GB201312332D0 (en) Cell locations
IL244579B (en) A method for connecting plastic pipes and a structure for the same connection
EP3087980A4 (fr) Comprimé à deux couches et son procédé de préparation
EP3088497A4 (fr) Briquettes et leur procédé de production
IL245048A0 (en) Mechanical-biological filter
EP2987470A4 (fr) Endoprothèse et son procédé de production
GB201421558D0 (en) Recommendation creation system
IL244578B (en) A method for connecting plastic pipes and a structure for the same connection
EP2892342A4 (fr) Antibiofilm et procédés de fabrication et d'utilisation associés